Found 7 matching trials
Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML
PHASE2The goal of this study is to assess the safety, tolerability, efficacy, pha...
Location
Centre Hospitalier Universitaire Grenoble Alpes
RVU120 (SEL120) in Patients with Relapse/Refractory Metastatic or Advanced Solid Tumors
PHASE1This is a phase 1/2, dose-escalation and expansion study investigating the ...
Status
Active Not Recruiting
Location
Beskidzkie Centrum Onkologii, Szpital Miejski im.
RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome
PHASE1This first-in-human study will evaluate RVU120 (SEL120), a novel small mole...
Location
Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics
RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis
PHASE2The objective of this clinical trial is to evaluate the efficacy (how well ...
Location
Policlinico Sant'Orsola-Malpighi
RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms
PHASE2This study will evaluate orally administered RVU120, a novel small molecule...
Status
Active Not Recruiting
Location
CHU Grenoble Alpes - Hôpital Michallon
RVU120 Rollover Study
PHASE2This is a multicenter rollover study to provide continued treatment to elig...
Status
Enrolling By Invitation
Location
Uniwersyteckie Centrum Kliniczne
Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML
PHASE2The goal of this study is to assess the safety, tolerability, anti-tumor ac...
Status
Active Not Recruiting
Location
Centre Hospitalier Universitaire Grenoble Alpes